Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study).

Abstract

BACKGROUND Differences in adverse events by gender and race/ethnicity have not been described extensively in randomized clinical trials of HIV antiretroviral therapy (ART). METHODS Antiretroviral-naive HIV-infected participants enrolled in a long-term randomized clinical trial of 3 different initial ART strategies -- protease inhibitor (PI), nonnucleoside… (More)
DOI: 10.1097/QAI.0b013e3181609da8

Topics

Cite this paper

@article{Tedaldi2008EthnicityRA, title={Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study).}, author={Ellen M. Tedaldi and Judith Absalon and Avis J. Thomas and Judith C. Shlay and Mary van den Berg-Wolf}, journal={Journal of acquired immune deficiency syndromes}, year={2008}, volume={47 4}, pages={441-8} }